JPRN-UMIN000005716招募中未知
aparoscopic sleeve gastrectomy with duonenal-jejunal bypass for Asian type 2 diabetics with BMI from 27.5 kg/m2 to 34.9 kg/m2: A prospective, non-randomized, single center, open label study - Laparoscopic sleeve gastrectomy with duonenal-jejunal bypass for Asian type 2 diabetics with BMI from 27.5 kg/m2 to 34.9 kg/m2
Weight Loss and Metabolic Surgery Center Yotsuya Medical Cube0 个研究点目标入组 50 人开始时间: 2011年6月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Cardiovascular event in the past 6 months. (2) Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. (3) Cardiac stress test indicating that surgery would not be safe. (4) Pulmonary embolus or thrombophlebitis in the past 6 months. (5) Cancer of any kind unless documented to be disease-free for 5 years. (6) Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy. (7) Serum creatinine less than 1.5 mg/dl. (8) Serum total bilirubin greater than the upper limit of normal, or alkaline phosphatase or ALT greater than twice the upper limit of normal. (9) History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or colon resection. (10) Gastric or duodenal ulcer in the past 6 months. (11) History of intra-abdominal sepsis. (12) Self-reported HIV-positive status, active tuberculosis, active malaria, chronic hepatitis B or C, cirrhosis, or inflammatory bowel disease. (13) Currently pregnant or nursing, or planning to become pregnant in the next 2 years. (14) History of alcohol or drug dependency in the past 5 years. (15) Active psychosocial or psychiatric problem that is likely to interfere with adherence to the protocol. (16) Presence of any chronic or debilitating disease that would make adherence to the protocol difficult. (17) 12-lead EKG indicating that surgery would not be safe. (18) Serum fasting c-peptide less than 1.0 ng/ml. (19) Exclusions may also be made at the discretion of the attending physician.
研究者
相似试验
招募中
1 期
aparoscopic sleeve gastrectomy with duodenojejunal bypass for patients with super morbid obesity or uncontrolable diabetes mellitusobesityJPRN-UMIN000009199Oita University Faculty of Medicine10
已完成
不适用
oop Duodeno-Jejunal Bypass with Sleeve Gastrectomy for type 2 diabetes mellitus in low BMI patientsType 2 diabetes mellitusNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN63241920E-Da Hospital (Taiwan)50
招募中
2 期
aparoscopic sleeve gastrectomy for moderate obesityobesityJPRN-UMIN000009200Oita University Faculty of Medicine10
已完成
不适用
Surgery versus stent for malignant gastro-duodenal obstructioISRCTN06702358Erasmus Medical Centre (Netherlands)150
尚未招募
不适用
Surgery versus stent for malignant gastro-duodenal obstruction.NL-OMON20885ZonMW150